| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.21 | 0.02 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.12 | 0.03 |